Dear Site,

Labcorp’s Clinical Development Business is now Fortrea. All invoices effective May 1, 2023 will
need to be updated to Fortrea as the entity name, replacing the name, Labcorp. This will not
affect the address, VAT, or registration numbers for all contracting entities except for contracts
made with Labcorp Drug Development Inc which now has an updated address (reference point
#13).
In addition, effective June 26, 2023, the iGPS email inbox for invoice submissions will be
changed to iGPSInvoiceProcessing@fortrea.com

As a kind reminder, please ensure the following guidelines are followed when submitting
invoices.
1) Effective October 3rd, 2023, incorrectly addressed invoices will be rejected if they are
not addressed to Fortrea.
2) The subject line of your email should always have the following information included:
Protocol number, PI Name, and Invoice number to avoid delays in processing.
3) Invoices should be addressed to the entity and address location as specified in your
contract (changing Labcorp to Fortrea as necessary)
4) Protocol number, PI name, Invoice date, Subject numbers, dates of service, itemized
details, etc should be delineated in your invoice. Kindly do not combine various line
items if they are broken down in your budget/contract. The closer the naming
convention is to your contract, the faster your invoice will process.
5) Please only submit one invoice at a time with any pertinent backup information attached,
as needed.
6) If you would like to add another email address to your remittance detail, please include
those details in your next invoice submission so that your payee can be updated with the
email addresses as specified.
7) Every submission made to the iGPS email inbox will result in system generated email
with an EVN number. This EVN number is unique to your invoice submission and can
be used for any inquiries regarding payment and will eliminate potential duplicate
processing. Please note, if you do not receive an EVN confirmation email, we did not
receive your submission.
8) Any inquiries made regarding your payment status should have the EVN number in the
subject line added to route it quicker. In addition, please remove any FWD or RE in your
email subject line or it may be kicked back as junk.
9) Invoices should be in English.
10) Any items not found on your original contract or amendment cannot be processed.
Kindly reach out to your clinical teams for questions on items not listed in your
contracted budget.

Labcorp's Clinical Development and Commercialization Services business is now Fortrea. 1

Learn more at fortrea.com. ©2023 Fortrea Inc. All rights reserved.

 11) For all countries except USA and Canada, please ensure your banking details on the
invoice match your fully executed contract, otherwise, you will need a Letter of
Notification completed or a contract amendment, reflecting the amended banking details
12) VAT should not be included if your contract entity is Labcorp Drug Development Inc or
Fortrea Inc
13) Labcorp Drug Development Inc will be replaced with Fortrea Inc and invoices should
reflect the new address of 8 Moore Drive, Durham NC,27709. All other contracting
entities will keep the same address.

Labcorp's Clinical Development and Commercialization Services business is now Fortrea. 2

Learn more at fortrea.com. ©2023 Fortrea Inc. All rights reserved.